Quang X. Pham, CEO and Chairman, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 8,285 shares at $4.26 ($36K) on 2026-06-03, disclosed to the SEC on 2026-06-05.
Scheduled sale ($36k) by CEO and Chairman, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.26 | 2,323 | $10K | 27.3% |
| 2 | $4.41 | 3,898 | $17K | 47.5% |
| 3 | $4.42 | 2,064 | $9K | 25.2% |
| Total | $4.37 avg | 8,285 | $36K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |